Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart P Richer

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Applied Ergonomics|September 26, 2008
Cataract halos: a driving hazard in aging populations. Implication of the Halometer DG test for assessment of intraocular light scatterMark A Babizhayev, Hayk Minasyan, Stuart P Richer
Clinical Interventions in Aging|June 9, 2009
N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient populationMark A Babizhayev, Leslie Burke, Philip Micans, et al.
The British Journal of Ophthalmology|June 20, 2015
The Diabetes Visual Function Supplement Study (DiVFuSS)A Paul Chous, Stuart P Richer, Jeffry D Gerson, et al.
BMC Ophthalmology|December 3, 2020
Foveal macular pigment dip in offspring of age-related macular degeneration patients is inversely associated with omega-3 indexGrant A Rutledge, Steven G Pratt, Stuart P Richer, et al.
Optometry (St. Louis, Mo.)|October 27, 2011
Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973Stuart P Richer, William Stiles, Kelly Graham-Hoffman, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Applied Ergonomics|September 26, 2008
Cataract halos: a driving hazard in aging populations. Implication of the Halometer DG test for assessment of intraocular light scatterMark A Babizhayev, Hayk Minasyan, Stuart P Richer
Clinical Interventions in Aging|June 9, 2009
N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient populationMark A Babizhayev, Leslie Burke, Philip Micans, et al.
The British Journal of Ophthalmology|June 20, 2015
The Diabetes Visual Function Supplement Study (DiVFuSS)A Paul Chous, Stuart P Richer, Jeffry D Gerson, et al.
BMC Ophthalmology|December 3, 2020
Foveal macular pigment dip in offspring of age-related macular degeneration patients is inversely associated with omega-3 indexGrant A Rutledge, Steven G Pratt, Stuart P Richer, et al.
Optometry (St. Louis, Mo.)|October 27, 2011
Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973Stuart P Richer, William Stiles, Kelly Graham-Hoffman, et al.
Pageof 1